8-K
Current Report
SUTRO BIOPHARMA, INC. Filed Acc 0000950170-25-038879
Results of operations · Exit or restructuring costs · Executive or director change
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading stro-20250313.htm…